UVA’s Chongzhi Zang, PhD, and collaborators have found answers, revealing how genetic material called chromatin interacts with other factors to switch genes on and off to carry out this essential transformation.
“Gut development is a fascinating dynamic process, from which we can learn how the same genome can create many different types of cells in different organs,” said Zang, of UVA’s Center for Public Health Genomics and UVA Cancer Center. “We knew the genes being used in different organs would start to show some differences in the early stages of development, but this was the first time that we found how such differences were controlled by chromatin during the organ-formation process.”
Understanding Organ Development
Zang and his colleagues, including collaborators led by Tae-Hee Kim, PhD, of the University of Toronto in Canada, used cutting-edge genomics technology called “single-cell ATAC-seq” to create a detailed “map” of the chromatin pattern changes that take place inside individual cells in the gut tube during organ formation in mice. In so doing, they have filled in many important gaps in our understanding of the organ-development process in mammals.
Advertisement
The team found that chromatin displays different dynamics in cells that become the liver, for example, than in cells that become the lungs. Chromatin interacts with what are called “transcription factors” in an elegant arrangement that trains the cells for the important jobs they are fated to hold.
It’s important that this complex process play out precisely. The researchers found that errors can have dire consequences, disrupting, for example, the healthy development of the pancreas and intestines in lab mice. Dramatic changes noted in the pancreas included the formation of many large, cyst-like structures.
The researchers note that “cell fate” errors occur in the early stages of pancreatic cancer, leading to precancerous lesions. So understanding the organ-development process and what can go wrong could offer important insights into the formation of certain cancerous tumors.
“A better understanding of how genes work in the genome during organ development can give us insights into the mechanisms underlying initiation of many types of cancer,” Zang said. “We use state-of-the-art technologies to tackle these complex problems and believe that these fundamental discoveries, one step at a time, will eventually inspire new therapeutic development and benefit cancer patients in the future.”
Source: Eurekalert
